https://doi.org/10.14573/altex.2511111
Thomas Hartung
Johns Hopkins Center for Alternatives to Animal Testing (CAAT),
New UK Roadmap to phase out animal testing makes the in vitro inhalation tox community smile!
The UK has just published a remarkable roadmap to phase out animal testing faster and scale up alternative methods, with concrete measures to support non‑animal science. New £75 million funding will help to make the path to regulation clearer for researchers.
For exposures to the lung, eye and skin, that’s a clear signal: regulators are looking for human‑relevant in vitro data, NAMs need realistic exposure methods at the air/liquid interface, and robust, reproducible setups will decide what actually gets accepted.
That’s where VITROCELL comes in: our exposure systems are already used worldwide to expose cells to gases and complex aerosols and to support next‑generation NAMs, including the AlveoliX AX12 Organ-on-Chip technology. They’re definitely ready for this roadmap.
📖 Please read the UK Department for Science, Innovation & Technology article
📖 Please read also the valuable comment by Thomas Hartung (Johns Hopkins Center for Alternatives to Animal Testing (CAAT)).
